QF
WHWK

QVT Financial’s Whitehawk Therapeutics WHWK Stock Holding History

QVT Financial’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.1M Hold
4,615,709
– – 1.24% 16
2026
Q1 		$15.9M Hold
4,615,709
– – 1.17% 15
2025
Q4 		$10.6M Hold
4,615,709
– – 0.91% 20
2025
Q3 		$8.33M Hold
4,615,709
– – 0.59% 21
2025
Q2 		$8.2M Buy
4,615,709
+100,000
+2% +$174K 0.73% 25
2025
Q1 		$7.64M Buy
4,515,709
+2,202,007
+95% +$5.75M 0.7% 21
2024
Q4 		$7.3M Buy
+2,313,702
New +$5.24M 0.65% 18

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

QVT Financial's WHWK Position: Q2 2026 in Review

QVT Financial held its Whitehawk Therapeutics (WHWK) position steady in Q2 2026 at 4,615,709 shares worth $21.1M. The position accounts for 1.24% of the portfolio, ranked #16.

QVT Financial first reported a position in WHWK in Q4 2024 and has held it in 7 quarters since. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • QVT Financial held 4,615,709 shares of Whitehawk Therapeutics worth $21.1M as of Q2 2026.
  • QVT Financial left its Whitehawk Therapeutics share count unchanged in Q2 2026.
  • Whitehawk Therapeutics made up 1.24% of QVT Financial's portfolio in Q2 2026, its #16 holding.
  • QVT Financial first reported a position in Whitehawk Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on QVT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.